Skip to content
GradedGrading live · 2026
LongevityGraded
Menu

Graded review

TruDiagnostic TruAge Review: Is the $229 Epigenetic Clock Worth It?

TruDiagnostic's TruAge uses the well-validated DunedinPACE clock — but no test proves the score predicts YOUR outcomes. An honest, evidence-graded review.

Researched & graded by Tom Vance · Lead Reviews Analyst
Last graded
Evidence scorecard

The one-sentence version

TruDiagnostic's TruAge is one of the better-built consumer epigenetic-age tests on the market — it runs a high-density methylation array and reports DunedinPACE, the most defensible pace-of-aging clock in the literature — and it still cannot tell you, the individual buyer, whether your supplement stack, your fasting protocol, or your last clinic visit actually changed how fast you are aging. Both of those things are true at the same time, and the gap between them is the whole review. The science behind the clock is real; the personal-tracking promise the price tag implies is not yet earned. For where biological-age testing sits in the wider toolkit, start with our deeper explainer on whether epigenetic clocks actually work and our pillar on longevity medicine: what's proven vs hyped.

What you actually get for ~$229

TruAge is a direct-to-consumer (DTC) DNA-methylation test. You order a kit, provide a blood sample (TruDiagnostic uses a finger-stick blood spot rather than saliva, which is a genuine quality point — blood methylation is the substrate most clocks were trained on), and the lab runs it on a high-density methylation array. Pricing sits in the low-to-mid hundreds depending on the panel tier and any subscription bundling — treat the ~$229 figure as current market positioning rather than a fixed law; DTC longevity pricing moves constantly. What comes back is a report headlined by an estimated biological age plus a set of clock outputs, most notably DunedinPACE, a "pace of aging" number where 1.0 means you are aging one biological year per chronological year and 1.2 means roughly 20% faster.

At a glance

TruAge / DunedinPACE
What it isDTC DNA-methylation test (blood spot, high-density array)
Headline outputEstimated biological age + DunedinPACE pace-of-aging rate
PriceLow-to-mid hundreds (~$229, current market positioning)
Regulatory statusLab-developed test — not FDA-cleared
Clock validated to predict populations?Yes — DunedinPACE associates with aging/mortality in cohorts
Proven to predict YOUR outcome?No — not validated as a modifiable personal target
A well-built test on a good clock — sold with a personal-tracking promise the science has not yet earned.

The two things that genuinely distinguish TruAge from a generic "spit-in-a-tube biological age" kit are worth naming, because they're real:

  • It reports DunedinPACE. Of all the clocks a consumer test could feature, this is the one with the best conceptual and empirical footing for tracking a rate of aging over time (more on why below).
  • It uses a high-density array on blood. That's a more serious analytical substrate than the low-coverage methods some cheaper kits rely on, and blood is the tissue the major clocks were validated in.

Neither of those, however, rescues the test from the structural limits every epigenetic clock shares.

Why DunedinPACE is the right clock to feature

Give the science its due. DunedinPACE (Belsky 2022) is not trained to guess your birthday like the first-generation Horvath clock1 was. It was calibrated against decades of longitudinal organ-system decline in a single birth cohort followed since 1972, so instead of estimating an age it estimates a rate2. That design is the most appealing thing a consumer could want from a longevity test: a speedometer, not an odometer.

It also has the single most important property for repeat testing — comparatively better reliability. A computational re-engineering effort (Higgins-Chen 2022) showed that the original first-generation clocks were noisy enough to be unfit for clinical-trial or longitudinal tracking, and built principal-component versions specifically to fix that; DunedinPACE was developed in that same reliability-conscious lineage3. And — crucially — DunedinPACE has been moved by an actual randomized intervention: in the CALERIE trial, two years of sustained caloric restriction slowed DunedinPACE relative to controls, the cleanest randomized signal that a clock of this type responds to a real intervention4. That is a legitimate feather in the cap of the clock. It is not yet proof about you.

The three things the price tag implies but the science doesn't deliver

Here is where an honest review has to slow the marketing down. TruAge is sold, implicitly, as a personal dashboard you can re-run to see if your protocol is "working." Three well-documented limits stand between that promise and reality.

1. A clock that predicts populations is not validated to predict your outcome

DunedinPACE and the mortality-trained clocks (GrimAge5, PhenoAge6) are validated as predictors across large groups: people whose methylation runs "fast" or "old" die sooner on average, even after adjusting for known risk factors, as the landmark blood-methylation mortality analysis first showed7. But "associates with mortality across thousands of people" is a completely different claim from "if I push my number down, I personally live longer." That second claim — that the clock is a valid, modifiable target rather than a passive marker — has not been demonstrated for any clock, DunedinPACE included. An intervention could lower your TruAge reading while leaving your actual disease risk untouched, and you would have no way to tell from the report. The field's own consensus work treats these clocks as legitimate but explicitly research-stage tools for intervention studies, not personal diagnostics89.

2. Test–retest noise can swamp the change you're hoping to see

Even the better clocks carry measurement noise. The same DNA sample, run twice, can return estimates that differ — and a detailed reliability study found that many widely used clocks have poor test–retest reproducibility, with first-generation clocks the worst offenders10. DunedinPACE is among the more reliable options, which is exactly why featuring it is the right call — but "more reliable than Horvath" is a low bar, and the honest framing is that the noise floor on any single re-test can be of the same order as the small change a 90-day supplement experiment might produce. If you test, change one thing, and re-test, an apparent "improvement" may be measurement variation dressed up as progress.

3. There is no standardized, FDA-cleared "biological age"

There is no regulatory floor here. TruAge is a laboratory-developed test, not an FDA-cleared diagnostic, and there is no canonical definition of "your biological age" that every lab must hit. Run two reputable methylation tests on the same person and they can disagree, because they use different clocks, arrays, normalization, and reference populations9. TruAge's choice to lead with DunedinPACE is a defensible one — but it is still a choice, and it means your number isn't comparable to a competitor's number or to a clinic's in-house clock.

Graded scorecard

  1. B
    DunedinPACE as a population pace-of-aging predictorModerate evidence

    Calibrated against decades of longitudinal decline; associates with aging across cohorts; slowed by randomized caloric restriction in CALERIE.

  2. B
    TruAge build quality (blood spot, high-density array)Moderate evidence

    Blood is the substrate clocks were trained on; a more serious method than low-coverage saliva kits. Better end of the DTC category.

  3. C
    TruAge as a personal protocol-tracking scoreboardWeak evidence

    Clock not validated as a modifiable individual target; single-test reproducibility noise can rival the change a short experiment produces.

  4. D
    A standardized, FDA-cleared 'biological age' numberInsufficient

    No regulatory floor; no canonical definition. Different reputable methylation tests can disagree on the same person.

Two separate axes: the clock's population science (strong-ish) versus the personal-tracking use case most buyers want (weak). Grades reflect the cited conclusions, not the marketing.

The grade, and how we got there

We grade TruAge on two separate axes, because conflating them is exactly the marketing trap:

  • As a serious build on a good clock: strong. The blood substrate, the high-density array, and the decision to report DunedinPACE put it at the better end of the consumer category. If you are going to buy a methylation test as a one-time curiosity or a rough risk signal, this is a reasonable one to buy.
  • As a tool to track whether your longevity protocol is working: weak. The clock isn't validated as a modifiable personal target, single-test noise can rival the change you're chasing, and there's no FDA-cleared standard behind the headline number. Re-subscribing every quarter to watch the figure wobble is paying to confirm nothing.

That split is why the letter grade lands in the middle rather than at either extreme. A genuinely good product wrapped around a genuinely unproven personal promise is, honestly graded, a B for the science and a C for the use case most people buy it for. The watch-out is the conflict baked into the broader category: when the same ecosystem sells you the test and the supplements meant to improve it, an unvalidated "you got younger" readout becomes a sales tool, not a diagnosis. We dissect a textbook version of that loop in the "8 years younger" alpha-ketoglutarate claim.

Who should and shouldn't buy it

  • Reasonable buyer: someone curious about a one-time, well-built methylation snapshot who will read the DunedinPACE number as a soft risk signal, not a scoreboard — and who won't reorganize their spending around it.
  • Poor fit: someone planning to re-test every few months to "optimize" a supplement stack. The noise and the missing surrogate-validation mean you'll mostly be buying measurement variance. A standard outcome-validated blood panel — ApoB, Lp(a) once, hs-CRP, HbA1c — does far more for that money, and we sort exactly which markers earn their place in what longevity biomarker panels actually test. If you mainly want a biological-age number, the open PhenoAge formula derives one from a basic blood panel for nothing — see free biological-age tests and calculators.

Bottom line

TruDiagnostic's TruAge is one of the more credible consumer epigenetic-age tests: blood-based, high-density array, and built around DunedinPACE — the clock with the strongest case for tracking a rate of aging, and the one a real randomized trial (CALERIE) actually moved. But none of that closes the gap that matters for a buyer: no test has shown that lowering your TruAge score makes you live longer, single-test noise can rival the change you're hoping to detect, and there's no FDA-cleared standard behind the number. Buy it, if at all, as a one-time curiosity from the better end of the category — not as a quarterly scoreboard for your supplement budget. For an independently graded look at the labs and clinics selling biological-age testing, see our longevity clinic rankings.

Frequently asked questions

Is TruDiagnostic TruAge accurate?

TruAge is one of the better-built consumer epigenetic-age tests — it uses a blood sample on a high-density methylation array and reports DunedinPACE, the clock with the strongest case for tracking a rate of aging. But 'accurate' is the wrong frame: there is no FDA-cleared standard for biological age, reputable tests can disagree on the same person, and the clock is validated to predict outcomes across large populations, not to tell you personally whether an intervention worked.

Can TruAge tell me if my supplements or protocol are working?

Not reliably. No epigenetic clock — DunedinPACE included — has been validated as a modifiable personal target, meaning lowering your score has never been shown to lower your actual disease risk. On top of that, test-retest noise on a single re-measurement can be as large as the small change a 90-day protocol might produce, so apparent 'improvements' are often measurement variation rather than real biological change.

Is the DunedinPACE clock that TruAge uses any good?

Yes, as population science. DunedinPACE estimates a pace of aging (1.0 = one biological year per chronological year) calibrated against decades of longitudinal organ decline, it is among the more reliable clocks, and — uniquely — it was slowed by a randomized intervention (two years of caloric restriction in the CALERIE trial). That makes it the right clock for a consumer test to feature. It still has not been proven to predict an individual buyer's future outcomes.

Is TruAge worth $229?

As a one-time curiosity or rough risk signal from the better end of the consumer category, it's a defensible purchase if you won't over-read the number. As a quarterly scoreboard to optimize a supplement stack, no — the clock isn't validated as a personal target and the noise will show wobble that isn't real progress. For the same money, an outcome-validated blood panel (ApoB, Lp(a) once, hs-CRP, HbA1c) does far more, and the free PhenoAge formula gives a biological-age number from a basic blood panel.

References

  1. Horvath S (2013). DNA methylation age of human tissues and cell types. Genome Biology. https://pubmed.ncbi.nlm.nih.gov/24138928/
  2. Belsky DW, Caspi A, Corcoran DL, et al. (2022). DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. https://pubmed.ncbi.nlm.nih.gov/35029144/
  3. Higgins-Chen AT, Thrush KL, Wang Y, et al. (2022). A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking. Nature Aging. https://pubmed.ncbi.nlm.nih.gov/36277076/
  4. Waziry R, Ryan CP, Corcoran DL, et al. (2023). Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nature Aging. https://pubmed.ncbi.nlm.nih.gov/37118425/
  5. Lu AT, Quach A, Wilson JG, et al. (2019). DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). https://pubmed.ncbi.nlm.nih.gov/30669119/
  6. Levine ME, Lu AT, Quach A, et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). https://pubmed.ncbi.nlm.nih.gov/29676998/
  7. Marioni RE, Shah S, McRae AF, et al. (2015). DNA methylation age of blood predicts all-cause mortality in later life. Genome Biology. https://pubmed.ncbi.nlm.nih.gov/25633388/
  8. Moqri M, Herzog C, Poganik JR, et al. (2023). Biomarkers of aging for the identification and evaluation of longevity interventions. Cell. https://pubmed.ncbi.nlm.nih.gov/37657418/
  9. Perri G, Mendonça N, Jagger C, et al. (2025). An Expert Consensus Statement on Biomarkers of Aging for Use in Intervention Studies. Journals of Gerontology Series A: Biological Sciences and Medical Sciences. https://pubmed.ncbi.nlm.nih.gov/39708300/
  10. Sugden K, Hannon EJ, Arseneault L, et al. (2020). Patterns of Reliability: Assessing the Reproducibility and Integrity of DNA Methylation Measurement. Patterns (New York). https://pubmed.ncbi.nlm.nih.gov/32885222/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

More graded reviews